Venrock Healthcare Capital Partners III, L.P. 13D and 13G filings for Crescent Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 6:05 pm Purchase | 2025-12-31 | 13G | CRESCENT BIOPHARMA, INC CBIO | Venrock Healthcare Capital Partners III, L.P. | 2,666,064 9.500% | 1,274,868 (+91.64%) | Filing |